Schlagwort: Mirko Scherer

TVM Capital Life Science has announced that it has achieved the first closing of China BioPharma Capital I at 50 Mio. USD. China BioPharma Capital I is a venture capital fund with subscription from Chongqing Lummy Pharmaceutical Co., Ltd. a pharmaceutical company based in Chongqing, China, which develops, manufactures and markets pharmaceuticals as well as health care products.